Capsion
SODIUM IODIDE (131|)
| Name | CAPSION |
| Pharmaceutical form | Capsule for therapy |
| Nuclide | Iodine 131 |
| Half life | 8.02 days |
| Availability | Every working day |
| Ordering deadline | The shipment day, before 11 a.m. |
| Total activity per capsule | From 50 MBq to37.00 MBq per capsule at calibration |
| Calibration | On request 1 - 4 days |
| Expiry | 21 days from the manufacturing date |
| Specific activity | ≥ 185 GBq/mg of iodine at calibration |
| Radiochemical purity | Iodide : ≥ 98%; Iodates + periodate ≤ 2.0%; (131I) - gelatine ≤ 2.0%; total impurities ≤ 2.0% |
| Radionuclidic purity | 131I ≥ 99.9%; 130I + 133I + 135I ≤ 0.1% |
| Storage | Not above 25°C |
| Indication | • Treatment of Grave’s disease, toxic multinodular goitre or autonomous nodules • Treatment of papillary and follicular thyroid carcinoma including metastatic disease |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
